Mariella G. Filbin, MD, PhD

Research Co-Director, Pediatric Neuro-Oncology Program


Assistant Professor of Pediatrics, Harvard Medical School
Appointment Phone: 617-632-2680


Treatment Centers
Clinical Interests
DIPG, Ependymomas, ETMR, High-grade gliomas, Pediatric brain tumors, Translational neuro-oncology


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA  02215


Board Certifications
Pediatric Hematology/Oncology, 2019
Pediatrics, 2013
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Pediatric Hematology/Oncology, 2017
Boston Children's Hospital, Pediatrics, 2013
Medical School
Medical University of Graz, Austria, 2004
Dr. Mariella Filbin earned her MD and PhD in biochemistry and molecular biology from the Medical University of Graz, Austria. After a pediatric residency at Boston Children’s Hospital, she completed a fellowship in pediatric hematology/oncology at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. She joined the faculty at Dana-Farber/Boston Children's as a pediatric neuro-oncologist in July 2017. In addition to her role in the treatment of patients with brain tumors, her research focuses on establishing cellular networks of tumor dependencies in pediatric brain tumors with the goal of finding new targeted therapies. Current areas of emphasis are: (1) utilizing single-cell transcriptomics to determine the tumor architecture and heterogeneity in pediatric brain tumors and (2) exploring the downstream effects of epigenetic driver mutations and their potential therapeutic applications in DIPG and high-grade gliomas.
Research Website

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.